|
Brian Bathgate, Ph.D., joined Charles River Laboratories in October 2004 upon the completion of the merger with Inveresk Research Group, where he served as Group Executive Vice President and President of Preclinical Europe Operations. In December 2004, Dr. Bathgate was named Corporate Vice President & President, European Preclinical Services. In 2006, Dr. Bathgate assumed responsibility for global Biopharmaceutical Services and in October 2007, he was named Corporate Senior Vice President.
Dr. Bathgate received his BSc degree from Glasgow University and his Ph.D., from Nottingham University. | 